Abstract:In the pharmaceutical industry, the unexpected appearance of crystalline forms could impact the therapeutic efficacy of an Active Pharmaceutical Ingredient (API). For quality control, a thorough qualitative and quantitative monitoring of pharmaceutical solid forms is essential to ensure the detection and the quantification of crystalline forms, wither different or with the same chemical composition (polymorphs) at a low detection level. The purpose of this paper was to review and highlight the importance of choosing adequate solid-state techniques for detection and quantification APIs that present polymorphism - based on limits of detection (LOD) and quantification (LOQ), pharmacopeias specifications, international guidelines and studies reported in the literature. To this study, the powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), Infrared and Raman spectroscopies and solid-state nuclear magnetic resonance (NMR) were the solid-state techniques analyzed. Additionally, the Argentine, Brazilian, British, European, International, Japanese, Mexican and the United States of America pharmacopeias were reviewed. Based on the analysis performed, the advantages and disadvantages of these techniques, as well as the LOD and LOQ values of APIs were reported. In comparison to these solid-state techniques, reference material used for identification analyses should be previously identified with the corresponding polymorph. Without this previous procedure, the patterns, the spectra, and DSC curves of the reference material can only be used to confirm the mixture of solid forms, not being able to specify which polymorphs are contained in the sample. A major advantage of PXRD is the use of the calculated diffraction patterns obtained from the Crystallographic Information Frameworks (CIFs) files which could be used as a reference pattern without any other information, assistance technique, or physical standards. Regarding the quantification aspect, different pharmacopeias suggest various methods such as the PXRD combining with Rietveld method, which can be used to obtain lower LOD values for minority phases in the mixture of different substances without the need for a calibration curve. Raman spectroscopy can detect polymorphs in small particles and solid-state NMR spectroscopy is a powerful technique for quantification not only crystalline but also crystalline-amorphous mixtures. Finally, this review intends to be a useful tool to control, with efficiency and accuracy, the polymorphism of APIs in pharmaceutical compounds.

Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns

Quantitative Measurement of Indomethacin Crystallinity in Indomethacin-Silica Gel Binary System Using Differential Scanning Calorimetry and X-ray Powder Diffractometry

Determination of traces of crystalline cefuroxime axetil content in cefuroxime axetil amorphous drug substance using powder X-Ray Diffraction ( PXRD ) Technique

Recent Advances in the Application of Characterization Techniques for Studying Physical Stability of Amorphous Pharmaceutical Solids

Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization

Quantitative Analysis of Amorphous Form in Indomethacin Binary Polymorphic Mixtures Using Infrared Spectroscopy Analytical Techniques Combined with Chemometrics Methods

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Quantifying Micromolar Crystallinity in Pharmaceutical Materials Utilizing 19F Solid-State NMR

Identification and Investigation of the Vibrational Properties of Crystalline and Co-Amorphous Drugs with Raman and Terahertz Spectroscopy

Structural Characterization of Pharmaceutical Cocrystals with the Use of Laboratory X-ray Powder Diffraction Patterns

Recent progress on crystallizations of amorphous pharmaceutical solids

Preparation, Characterization and in Vivo Evaluation of Pharmacological Activity of Different Crystal Forms of Ibuprofen

Atomic-level structure determination of amorphous molecular solids by NMR

A Method to Evaluate the Effect of Contact with Excipients on the Surface Crystallization of Amorphous Drugs

Evaluation of drug-polymer solubility curves through formal statistical analysis: comparison of preparation techniques

Structural analysis of pharmaceutical tablets using two-dimensional X-ray absorption fine-structure spectroscopy and its combination with X-ray computed tomography

Application of X-ray Powder Diffraction to Quantitative Analysis of Pharmaceutical Polymorphism

Identification and quantification techniques of polymorphic forms - A review

Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods

Evaluation of amorphous solid dispersion properties using thermal analysis techniques

X‐Ray Crystallography and Crystal Packing Analysis